Translational Dev -A -CW26TDACWPreferred / convertible
13F holders, Q1 2026 (March 31)
32holders −1
0new positions
1sold out
$0.13avg. 13F price*
At the end of Q1 2026, 32 institutions reported holding Translational Dev -A -CW26 (TDACW) in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holders were Magnetar Financial LLC ($96K), Shaolin Capital Management LLC ($77K) and Healthcare of Ontario Pension Plan Trust Fund ($72K).
Company
Translational Dev -A -CW26
CUSIP
G9008W113
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
Institutions
Total Value
New Positions
0
$0
Exits
1
$27
All 13F filers, Q4 2025 → Q1 2026: 25,000 shares bought and 132,320 shares sold, net −107,320 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.